LLY

986.64

-1.73%↓

JNJ

228.71

+0.86%↑

ABBV

209.5

-0.44%↓

UNH

389.84

-0.97%↓

AZN

183.98

+1.3%↑

LLY

986.64

-1.73%↓

JNJ

228.71

+0.86%↑

ABBV

209.5

-0.44%↓

UNH

389.84

-0.97%↓

AZN

183.98

+1.3%↑

LLY

986.64

-1.73%↓

JNJ

228.71

+0.86%↑

ABBV

209.5

-0.44%↓

UNH

389.84

-0.97%↓

AZN

183.98

+1.3%↑

LLY

986.64

-1.73%↓

JNJ

228.71

+0.86%↑

ABBV

209.5

-0.44%↓

UNH

389.84

-0.97%↓

AZN

183.98

+1.3%↑

LLY

986.64

-1.73%↓

JNJ

228.71

+0.86%↑

ABBV

209.5

-0.44%↓

UNH

389.84

-0.97%↓

AZN

183.98

+1.3%↑

Kodu・Aktsiate loetelu・10X Genomics Inc (Class A)

10X Genomics Inc (Class A)

Suletud

SektorTervishoid

21.46 1.47

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

20.93

Max

22.29

Põhinäitajad
By Trading Economics
Sissetulek	2.8M -13M
Müük	-15M 151M
Aktsiakasum	0.072
Kasumimarginaal	-8.93
Töötajad	1,178
EBITDA	2.5M -17M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+13.68% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	6. aug 2026

Turustatistika
By TradingEconomics
Turukapital	-190M 2.6B
Eelmine avamishind	19.99
Eelmine sulgemishind	21.46

Uudiste sentiment

By Acuity

50%

136 / 345 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

8.32 / 8.63 Toetus ja vastupanu

10X Genomics Inc (Class A) Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

17. mai 2026, 23:53 UTC

Omandamised, ülevõtmised, äriostud

Prudential PLC to Buy Majority Stake in India Life Insurer for $389 Million

15. mai 2026, 22:47 UTC

Kuumad aktsiad

Stocks to Watch: Macy's, Delta, UnitedHealth, NextNRG

15. mai 2026, 22:16 UTC

Omandamised, ülevõtmised, äriostud

Canadian Tribunal Gives Keyera, Plains Until Late June to Rebut Bid to Undo Merger

15. mai 2026, 22:00 UTC

Suurimad hinnamuutused turgudel

Delta Air Shares Rise as Berkshire Hathaway Discloses Stake

15. mai 2026, 18:09 UTC

Suurimad hinnamuutused turgudel

Palo Alto Shares Head for Record-High Close, Analysts See Benefits to Identity Security Pivot

17. mai 2026, 23:50 UTC

Market Talk

Gold Consolidates; May be Weighed by Fed Rate-Hike Expectations -- Market Talk

17. mai 2026, 23:43 UTC

Market Talk

Global Equities Roundup: Market Talk

17. mai 2026, 23:43 UTC

Market Talk

Nikkei May Decline Amid Middle East Uncertainty -- Market Talk

17. mai 2026, 23:36 UTC

Market Talk

Oil Rises Amid Prospects of Prolonged Strait of Hormuz Closure -- Market Talk

17. mai 2026, 23:07 UTC

Omandamised, ülevõtmised, äriostud

UOB: Transactions Part of Group's Capital Reallocation Strategy

17. mai 2026, 23:06 UTC

Omandamised, ülevõtmised, äriostud

UOB: Share Sale Agreements Entered With Singland Properties

17. mai 2026, 23:05 UTC

Omandamised, ülevõtmised, äriostud

UOB: Divestments' Aggregate Consideration of S$299M in Cash

17. mai 2026, 22:31 UTC

Omandamised, ülevõtmised, äriostud

Prudential PLC to Fund Stake Acquisition via Internal Resources

17. mai 2026, 22:31 UTC

Omandamised, ülevõtmised, äriostud

Prudential PLC to Acquire Stake for $389 Million

17. mai 2026, 22:30 UTC

Omandamised, ülevõtmised, äriostud

Prudential PLC to Acquire 75% Stake in Bharti Life Insurance

16. mai 2026, 16:27 UTC

Omandamised, ülevõtmised, äriostud

NextEra Is In Talks to Buy Dominion, Report Says. What a Deal Could Mean. -- Barrons.com

16. mai 2026, 15:26 UTC

Omandamised, ülevõtmised, äriostud

NextEra Energy Near Deal for Rival Utility Dominion -- WSJ

16. mai 2026, 08:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

15. mai 2026, 22:17 UTC

Omandamised, ülevõtmised, äriostud

Berkshire Boosted Stake in Alphabet in First Quarter, Bought Delta Air, Sold Visa, Mastercard -- Barrons.com

15. mai 2026, 21:59 UTC

Omandamised, ülevõtmised, äriostud

Stanley Druckenmiller Just Exited Alphabet. TCI Fund Management Is Buying. -- Barrons.com

15. mai 2026, 21:50 UTC

Omandamised, ülevõtmised, äriostud

Berkshire Boosted Stake in Alphabet in First Quarter, Bought Delta Air, Sold Visa, Mastercard -- Barrons.com

15. mai 2026, 21:30 UTC

Omandamised, ülevõtmised, äriostud

Bill Ackman's Pershing Square Bets on Microsoft's AI Ambitions With New Stake -- 4th Update

15. mai 2026, 21:16 UTC

Market Talk

Canada Oil Producers Expect Govt Cash Before Building Pathways Project -- Market Talk

15. mai 2026, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

15. mai 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

15. mai 2026, 20:19 UTC

Kuumad aktsiad

Stocks to Watch Recap: Intel, Nvidia, Amgen, LVMH -- WSJ

15. mai 2026, 19:41 UTC

Omandamised, ülevõtmised, äriostud

SanDisk Stock Is Up 494% This Year. Insiders Are Cashing In on the AI-Fueled Surge. -- Barrons.com

15. mai 2026, 19:35 UTC

Market Talk

Oil Futures Settle Higher on Inventory Worries -- Market Talk

15. mai 2026, 19:33 UTC

Market Talk

U.S. Natural Gas Futures Rise as Weather Heats Up -- Market Talk

15. mai 2026, 18:35 UTC

Tulu

Xanadu Quantum Revenue Increases Fourfold. Why the Stock Is Falling. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

10X Genomics Inc (Class A) Prognoos

Hinnasiht

By TipRanks

13.68% tõus

12 kuu keskmine prognoos

Keskmine 24.1 USD 13.68%

Kõrge 32 USD

Madal 20 USD

Põhineb 12 Wall Streeti analüütiku instrumendi 10X Genomics Inc (Class A) 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

12 ratings

Osta

Hoia

Müü

Põhineb 12 analüütiku instrumendi 10X Genomics Inc (Class A) aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

8.32 / 8.63Toetus ja vastupanu

Recent bullish events outweigh bearish events.

There are no events.

Sentiment

By Acuity

136 / 345 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest 10X Genomics Inc (Class A)

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.